Form 4: CorMedix Director Reports Stock Transaction
Insider Transaction (Form 4)
Janet Dillione, a Director of CorMedix Inc., reported multiple transactions in common stock on September 18, 2026.
Summary
- Option exercise/conversion: acquired 48,909 Common Stock on September 18, 2026; holds 117,835 after (Direct).
- Option exercise/conversion: disposed of 48,909 Phantom Stock on September 18, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Janet Dillione — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-18 | Option exercise/conversion | Common Stock | 48,909 | — | — | 117,835 |
| 2026-09-18 | Option exercise/conversion | Phantom Stock | 48,909 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-18 | Option exercise/conversion (48,909 shares) |
| 2026-09-18 | Option exercise/conversion (48,909 shares) |
Keywords
insider transaction, Form 4, CRMD, CorMedix Inc., neutral, Janet Dillione
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.